Back
Quanterix Corp. 10K Form
Sell
10
QTRX
Quanterix Corp.
Last Price:
$3.79
Seasonality Move:
11.43%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-04 | 10Q | QTRX/Quanterix Corp. Quarterly |
| 2020-05-07 | 10Q | QTRX/Quanterix Corp. Quarterly |
| 2020-03-13 | 10K | QTRX/Quanterix Corp. Annual |
| 2019-11-08 | 10Q | QTRX/Quanterix Corp. Quarterly |
| 2019-08-06 | 10Q | QTRX/Quanterix Corp. Quarterly |
| 2019-05-10 | 10Q | QTRX/Quanterix Corp. Quarterly |
Receive QTRX News And Ratings
See the #1 stock for the next 7 days that we like better than QTRX
QTRX Financial Statistics
Sales & Book Value
| Annual Sales: | $138.9M |
|---|---|
| Cash Flow: | $-16.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.33 |
| Price / Book: | 0.66 |
Profitability
| EPS (TTM): | -2.52320 |
|---|---|
| Net Income (TTM): | $-107.2M |
| Gross Margin: | $65M |
| Return on Equity: | -34.58% |
| Return on Assets: | -25.77% |
Quanterix Corp. Earnings Forecast
Key Quanterix Corp. Financial Ratios
-
The Gross Profit Margin over the past 11 years for QTRX is 46.77%.
-
The Selling, General & Administrative Expenses for QTRX have been equal to 99.97% of Gross Profit Margin.
-
The Research & Development expenses have been 22.19% of Revenue.
-
The Net Earning history of QTRX is -77.14% of Total Revenues.
-
Per Share Earnings over the last 11 years have been positive in 3 years.
Quanterix Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | QTRX |
| CUSIP: | 74766Q |
| Website: | quanterix.com |
Debt
| Debt-to-Equity Ratio: | 0.13 |
|---|---|
| Current Ratio: | 2.84 |
| Quick Ratio: | 2.01 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
QTRX Technical Analysis vs Fundamental Analysis
Sell
10
Quanterix Corp. (QTRX)
is a Sell
Is Quanterix Corp. a Buy or a Sell?
-
Quanterix Corp. stock is rated a SellThe current Quanterix Corp. [QTRX] share price is $3.79. The Score for QTRX is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.